InsiderTrades

Form 4 for TECH Bio-Techne

Accepted 2023-09-01 00:00:00 ET · period of report 2023-08-30 · accession 0001062993-23-017413 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-09-01 2023-08-30 TECH Nusse Roeland Dir M - OptEx $22.40 +32.0K 44.8K +250% +$716.8K
D 2023-09-01 2023-08-30 TECH Nusse Roeland Dir S - Sale+OE $80.32 -8,939 51.9K -15% -$718.0K
DM 2023-09-01 2023-08-30 TECH Nusse Roeland Dir M - OptEx $0.00 -32.0K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-08-30 M A 16,000 $22.95 60,811 D — —
2 Common Common Stock 2023-08-30 M A 16,000 $21.85 44,811 D — —
3 Common Common Stock 2023-08-30 S D 8,939 $80.32 51,872 D — — (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.09 to $80.78, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4 Derivative Stock Options (Right to Buy) 2023-08-30 M D 16,000 $0.00 0 D $21.85 · 2013-10-31 to 2023-10-30 16,000 Common Stock
5 Derivative Stock Options (Right to Buy) 2023-08-30 M D 16,000 $0.00 0 D $22.95 · 2014-10-30 to 2024-10-30 16,000 Common Stock